AU4344696A - Oligonucleotide-dendrimer conjugates - Google Patents

Oligonucleotide-dendrimer conjugates

Info

Publication number
AU4344696A
AU4344696A AU43446/96A AU4344696A AU4344696A AU 4344696 A AU4344696 A AU 4344696A AU 43446/96 A AU43446/96 A AU 43446/96A AU 4344696 A AU4344696 A AU 4344696A AU 4344696 A AU4344696 A AU 4344696A
Authority
AU
Australia
Prior art keywords
oligonucleotide
dendrimer conjugates
dendrimer
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43446/96A
Other languages
English (en)
Inventor
Robert Haner
Konstantinos Skobridis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU4344696A publication Critical patent/AU4344696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AU43446/96A 1994-12-21 1995-12-13 Oligonucleotide-dendrimer conjugates Abandoned AU4344696A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH3854/94 1994-12-21
CH385494 1994-12-21
CH4795 1995-01-09
CH47/95 1995-01-09
PCT/EP1995/004933 WO1996019240A1 (en) 1994-12-21 1995-12-13 Oligonucleotide-dendrimer conjugates

Publications (1)

Publication Number Publication Date
AU4344696A true AU4344696A (en) 1996-07-10

Family

ID=25683356

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43446/96A Abandoned AU4344696A (en) 1994-12-21 1995-12-13 Oligonucleotide-dendrimer conjugates

Country Status (9)

Country Link
EP (1) EP0790837A1 (ja)
JP (1) JPH10510822A (ja)
AU (1) AU4344696A (ja)
CA (1) CA2206915A1 (ja)
FI (1) FI972548A (ja)
HU (1) HUT77521A (ja)
IL (1) IL116456A0 (ja)
NO (1) NO972868L (ja)
WO (1) WO1996019240A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563255A (en) * 1994-05-31 1996-10-08 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
US5744460A (en) * 1996-03-07 1998-04-28 Novartis Corporation Combination for treatment of proliferative diseases
AU745309B2 (en) * 1997-05-28 2002-03-21 Peter E. Nielsen Conjugated peptide nucleic acids having enhanced cellular uptake
GB9718129D0 (en) * 1997-08-27 1997-10-29 Isis Innovation Branched structures
US6287765B1 (en) * 1998-05-20 2001-09-11 Molecular Machines, Inc. Methods for detecting and identifying single molecules
FR2906532B1 (fr) 2006-09-28 2008-12-12 Biomerieux Sa Nouvel oligonucleotide marque
FR2933410B1 (fr) 2008-07-04 2010-08-20 Biomerieux Sa Nouvelle sonde de detection
TW202043256A (zh) 2019-01-10 2020-12-01 美商健生生物科技公司 前列腺新抗原及其用途
CN114980920A (zh) 2019-11-18 2022-08-30 詹森生物科技公司 基于突变体calr和jak2的疫苗及其用途
CN112898580B (zh) * 2019-12-03 2022-11-08 安序源生物科技(深圳)有限公司 测序试剂
CN112898575B (zh) * 2019-12-03 2022-10-21 深圳清华大学研究院 树杈状大分子修饰的核苷酸的制备方法
WO2022009051A1 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. A method for determining responsiveness to prostate cancer treatment
WO2022009052A2 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. Prostate neoantigens and their uses
WO2022009049A1 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. Prostate neoantigens and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054678T5 (es) * 1986-08-18 1997-09-16 Dow Chemical Co Conjugados estrella.
US5714166A (en) * 1986-08-18 1998-02-03 The Dow Chemical Company Bioactive and/or targeted dendrimer conjugates
IL107715A0 (en) * 1992-11-25 1994-02-27 Baxter Int Water soluble non-immunogenic polyamide cross-linking agents
AU681735C (en) * 1993-07-14 2002-02-21 Regents Of The University Of California, The Self-assembling polynucleotide delivery system comprising dendrimer polycations
IT1270994B (it) * 1994-03-18 1997-05-26 Bracco Spa Macromolecole ramificate a struttura poliossialchilica e loro usi

Also Published As

Publication number Publication date
CA2206915A1 (en) 1996-06-27
NO972868L (no) 1997-08-19
HUT77521A (hu) 1998-05-28
WO1996019240A1 (en) 1996-06-27
FI972548A0 (fi) 1997-06-16
FI972548A (fi) 1997-06-23
IL116456A0 (en) 1996-03-31
JPH10510822A (ja) 1998-10-20
NO972868D0 (no) 1997-06-20
EP0790837A1 (en) 1997-08-27

Similar Documents

Publication Publication Date Title
AU7101094A (en) Factor ix - polymeric conjugates
AU6029594A (en) Factor viii - polymeric conjugates
AU3304795A (en) Bisresorcinyltriazines
AU2832295A (en) Cytoanalyzer
AU3304995A (en) 2-Hydroxyphenyltriazines
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU4131596A (en) Polyglycomers
AU4044795A (en) Handleset
AU4344696A (en) Oligonucleotide-dendrimer conjugates
AU2308295A (en) Heterocyclylbenzonitriles
AU1963395A (en) Boom-structure
AU4029295A (en) Thienopyridones
AU7469594A (en) Poop-scoop
AU3166195A (en) Acylimidazopyridines
AU4590996A (en) Boekomslag
AUPM365494A0 (en) Pre-chiller
AU3166095A (en) Benzylimidazopyridines
AU3446995A (en) Biodestumping
AU1603595A (en) Meso-azanoradamantanes
AU2411395A (en) Hydrocopter
AUPM374794A0 (en) Compartmentalizer
AU3417395A (en) Hydro-ethano-indeno-pyridines
AU661263B3 (en) Rotakite
AU658811B3 (en) Bum-bag
AU693176C (en) Campervan